Zurich researchers develop small gene-editing scissors
Zurich researchers overcome efficiency hurdle of compact gene scissors
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Zurich researchers develop small gene-editing scissors
Zurich researchers have developed new gene scissors that are much smaller than the familiar Crispr gene scissors and can therefore be transported more easily to the genetic material in cells.
This content was published on
3 minutes
Keystone-SDA
Deutsch
de
Zürcher Forscher überwinden Effizienz-Hürde von kompakter Genschere
Original
Attempts to create a more compact version of CRISPR gene scissors has been difficult. To date, small alternatives have functioned less efficiently the University of Zurich (UZH) explained in a press release on Monday. Zurich researchers have now overcome this hurdle with improvements to the mini gene scissors. The researchers presented the technology in a study published on Monday in the scientific journal Nature Methods.
CRISPR-Cas technology has revolutionised medicine, biotechnology and agriculture. In 2020, researchers Emmanuelle Charpentier and Jennifer Doudna received a Nobel Prize for their discovery of the technology. The tools can be programmed to find a specific location in the DNA and modify the genetic information. This makes it possible to restore a disease-causing mutation in the DNA to a healthy state.
More
More
CRISPR: Is Switzerland ready to embrace gene editing in agriculture?
This content was published on
Switzerland’ two decade-long moratorium on genetically modified crops could make an exception for gene editing.
However, these CRISPR-Cas gene scissors are relatively bulky, as study author, Kim Marquart, explained to the Keystone-SDA news agency. According to the researcher, this bulkiness poses a challenge for efficient transport into the cells in which the genetic material is located.
Researchers have recently been trying to use the much smaller evolutionary ancestor of the Cas12 protein, the TnpB protein, as gene scissors. The compact TnpB protein has already proven its worth for genome editing in human cells, albeit with low efficiency and limited accuracy, according to the UZH.
The researchers from the University of Zurich, in partnership with the Swiss technology institute ETH Zurich, optimised TnpB so that it edits the DNA of mammalian cells more efficiently than the original protein. They successfully used this in an initial test on mice.
“We were able to edit a gene that regulates cholesterol levels, thereby reducing the cholesterol in treated mice by nearly 80%,” says Gerald Schwank, who led the research team. “The goal is to develop similar gene editing strategies in humans in order to treat patients suffering from hypercholesterolemia.”
Translated from German by DeepL/jdp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
This content was published on
Solar energy pioneer Raphaël Domjan and his team continued preparations for the altitude record attempt at 10,000 metres with the SolarStratos solar aircraft.
This content was published on
Cattle in the canton of Geneva and in the neighbouring region of Terre Sainte in the canton of Vaud are being vaccinated against the contagious viral skin nodule disease. The first cases of the animal disease were reported at the end of June in France, just outside Geneva.
Fewer attacks on Swiss ATMs but their future remains uncertain
This content was published on
Bank ATMs in Switzerland are less prone to attacks by criminals, but their future remains uncertain given the less active use of cash by the population.
This content was published on
A series of rockfalls occurred above the village of Brienz between 9 and 12 July. According to the municipality of Albula, the overall situation remains tense. Several people disregarded the ban on entering the area around the village.
This content was published on
Arosa Bergbahnen achieved the highest figure in its 95-year history in the 2024/25 financial year with net revenue of CHF 37 million. Arosa Lenzerheide was able to capitalise on strengths such as snow reliability and the size of the ski area in a long winter season, the company announced on Thursday.
This content was published on
Unknown perpetrators stole ceramic dental implants during a break-in at a company in Oensingen, northern Switzerland, on Tuesday night.
Euro 2025: Bern prepares for massive parade ahead of Switzerland-Spain game
This content was published on
The last Euro 2025 match to be played in Bern, the quarterfinal between Spain and Switzerland at 9pm on Friday, promises to be a great celebration of football.
Clariant faces further ethylene price-fixing claim
This content was published on
Swiss chemicals group Clariant is facing a further claim for damages in connection with ethylene price-fixing agreements.
This content was published on
The Grande Dixence dam in Lower Valais is closed to visitors due to a rockfall last weekend. The nearby hotel also had to temporarily suspend operations for safety reasons.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.